-
Je něco špatně v tomto záznamu ?
Advances in the methodological approach to friction period estimation: A European perspective
P. Hanly, M. Ortega Ortega, A. Pearce, I. Soerjomataram, L. Sharp
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- lidé MeSH
- náklady na zdravotní péči * MeSH
- osobní újma zaviněná nemocí * MeSH
- tření MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Česká republika MeSH
- Evropa MeSH
- Norsko MeSH
- Řecko MeSH
- Spojené království MeSH
- Švýcarsko MeSH
The friction cost approach (FCA) estimates the productivity costs of disease from an employer's perspective but the lack of estimates of friction periods in different countries limits its use. Our aim was to use labour market aggregates to generate two alternative estimates of the friction period for European countries and to apply the FCA to illustrate the impact on cancer-related lost productivity costs. We included thirty countries (EU 27 + the United Kingdom, Switzerland and Norway). Base-case Method 1BC used annual Dutch vacancy stock and flow data (2001-2019) to estimate friction periods for this country. A regression model was employed using Dutch data and country-specific vacancy and unemployment rates to generate country-specific friction period estimates for the other 29 countries. Alternative Method 2ALT used country-specific newly occupied jobs as a proxy vacancy flow variable and vacancy stock data to generate friction period estimates. These were applied, within the FCA, to premature cancer mortality data (from GLOBOCAN2018) for all cancers combined for Western European countries. Costs are in €2018. Method 1BC estimated friction periods in 2018 ranged from 70.8 days for Greece to 145.9 days for the Czech Republic, with a mean duration of 95.3 days. Method 2ALT produced a mean friction period of 80.0 days. On average, across countries, Method 2ALT friction periods were 15.4 days (-18.5%) shorter than Method 1BC estimates. Friction period estimates over the last decade were shorter than those for 2018 reflecting lower vacancy rates. Total cancer premature mortality costs according to FCA Method 1BC amounted to €1.0 billion in 2018 for Western Europe compared to €0.99 billion for Method 2ALT. We developed two alternative - and viable - methods to estimate country-specific friction periods. These approaches will enable researchers to apply the FCA to estimate the productivity cost of diseases across Europe from an employer's perspective.
International Agency for Research on Cancer 150 Cours Albert Thomas 69372 Lyon CEDEX 08 France
School of Business National College of Ireland Mayor Street Dublin 1 Ireland
Sydney School of Public Health The University of Sydney NSW 2006 Australia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21019937
- 003
- CZ-PrNML
- 005
- 20210830101538.0
- 007
- ta
- 008
- 210728s2020 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.socscimed.2020.113289 $2 doi
- 035 __
- $a (PubMed)32836019
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Hanly, Paul $u School of Business, National College of Ireland, Mayor Street, Dublin 1, Ireland. Electronic address: paul.hanly@ncirl.ie
- 245 10
- $a Advances in the methodological approach to friction period estimation: A European perspective / $c P. Hanly, M. Ortega Ortega, A. Pearce, I. Soerjomataram, L. Sharp
- 520 9_
- $a The friction cost approach (FCA) estimates the productivity costs of disease from an employer's perspective but the lack of estimates of friction periods in different countries limits its use. Our aim was to use labour market aggregates to generate two alternative estimates of the friction period for European countries and to apply the FCA to illustrate the impact on cancer-related lost productivity costs. We included thirty countries (EU 27 + the United Kingdom, Switzerland and Norway). Base-case Method 1BC used annual Dutch vacancy stock and flow data (2001-2019) to estimate friction periods for this country. A regression model was employed using Dutch data and country-specific vacancy and unemployment rates to generate country-specific friction period estimates for the other 29 countries. Alternative Method 2ALT used country-specific newly occupied jobs as a proxy vacancy flow variable and vacancy stock data to generate friction period estimates. These were applied, within the FCA, to premature cancer mortality data (from GLOBOCAN2018) for all cancers combined for Western European countries. Costs are in €2018. Method 1BC estimated friction periods in 2018 ranged from 70.8 days for Greece to 145.9 days for the Czech Republic, with a mean duration of 95.3 days. Method 2ALT produced a mean friction period of 80.0 days. On average, across countries, Method 2ALT friction periods were 15.4 days (-18.5%) shorter than Method 1BC estimates. Friction period estimates over the last decade were shorter than those for 2018 reflecting lower vacancy rates. Total cancer premature mortality costs according to FCA Method 1BC amounted to €1.0 billion in 2018 for Western Europe compared to €0.99 billion for Method 2ALT. We developed two alternative - and viable - methods to estimate country-specific friction periods. These approaches will enable researchers to apply the FCA to estimate the productivity cost of diseases across Europe from an employer's perspective.
- 650 12
- $a osobní újma zaviněná nemocí $7 D017281
- 650 _2
- $a tření $7 D017276
- 650 12
- $a náklady na zdravotní péči $7 D017048
- 650 _2
- $a lidé $7 D006801
- 651 _2
- $a Česká republika $7 D018153
- 651 _2
- $a Evropa $7 D005060
- 651 _2
- $a Řecko $7 D006115
- 651 _2
- $a Norsko $7 D009664
- 651 _2
- $a Švýcarsko $7 D013557
- 651 _2
- $a Spojené království $7 D006113
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Ortega Ortega, Marta $u Applied Economics, School of Economics and Business, Complutense University of Madrid, Campus de Somosaguas, 28223, Pozuelo de Alarcón, Madrid, Spain. Electronic address: martao@ucm.es
- 700 1_
- $a Pearce, Alison $u Sydney School of Public Health, The University of Sydney, NSW, 2006, Australia. Electronic address: alison.pearce@sydney.edu.au
- 700 1_
- $a Soerjomataram, Isabelle $u International Agency for Research on Cancer, 150 Cours Albert Thomas, 69372, Lyon, CEDEX 08, France. Electronic address: Soerjomataraml@iarc.fr
- 700 1_
- $a Sharp, Linda $u Population Health Sciences Institute, Newcastle University Centre for Cancer, Sir James Spence Institute, Royal Victoria Infirmary, Queen Victoria Road, Newcastle Upon Tyne, NE1 4LP, United Kingdom. Electronic address: linda.sharp@ncl.ac.uk
- 773 0_
- $w MED00008691 $t Social science & medicine (1982) $x 1873-5347 $g Roč. 264, č. - (2020), s. 113289
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32836019 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210728 $b ABA008
- 991 __
- $a 20210830101538 $b ABA008
- 999 __
- $a ok $b bmc $g 1690689 $s 1140383
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 264 $c - $d 113289 $e 20200815 $i 1873-5347 $m Social science & medicine $n Soc Sci Med $x MED00008691
- LZP __
- $a Pubmed-20210728